Global Artificial Intelligence (AI) Electrocardiogram (ECG) Market Size, Share, and COVID-19 Impact Analysis, By Type (On-Premised and Cloud-Based), By Application (Hospital and Clinic), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Artificial Intelligence (AI) Electrocardiogram (ECG) Market Insights Forecasts to 2035

• The Global Artificial Intelligence (AI) Electrocardiogram (ECG) Market Size Was Estimated at USD 1.40 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 19.41% from 2025 to 2035
• The Worldwide Artificial Intelligence (AI) Electrocardiogram (ECG) Market Size is Expected to Reach USD 9.85 Billion by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

According to a research report published by Spherical Insights and Consulting, the global Artificial Intelligence (AI) Electrocardiogram (ECG) market size was worth around USD 1.40 Billion in 2024 and is predicted to grow to around USD 9.85 Billion by 2035 with a compound annual growth rate (CAGR) of 19.41% from 2025 and 2035. The market for artificial intelligence (AI) electrocardiogram (ECG) has a number of opportunities to grow due to increasing data availability and the development of more sophisticated algorithms.

Market Overview

The global artificial intelligence (AI) electrocardiogram (ECG) market encompasses the use of artificial intelligence and machine learning algorithms for analyzing ECG data for more accurate, efficient, and early detection of cardiovascular diseases. Artificial intelligence (AI) in electrocardiography aids in assisting the diagnosis, stratification, and management, as AI algorithms help clinicians to improve various clinical processes where ECG is involved to deal with cardiovascular diseases, predicting risk and enabling faster interpretation. Emergence of AI-enabled smartwatch ECG, which is a recent advancement in AI-ECG, enabling the early prediction and prevention of heart failure rehospitalization.

Innovation and market expansion are anticipated as a result of major players' growing focus on R&D and the expanding partnerships for promoting AI in healthcare, including cardiac care. For instance, in July 2023, PMcardio, a market leader in AI-powered cardiovascular diagnostics, announced a research and development partnership with Cardiovascular Research Center Aalst, a world-renowned authority in cardiology. The emergence of wearable ECGs, which are compact systems for real-time heart monitoring used for improving the detection of arrhythmias and myocardial infarction, is driving a huge surge in the global artificial intelligence (AI) electrocardiogram (ECG) market.    

Report Coverage

This research report categorizes the artificial intelligence (AI) electrocardiogram (ECG) market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the artificial intelligence (AI) electrocardiogram (ECG) market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the artificial intelligence (AI) electrocardiogram (ECG) market. 

Driving Factors

The artificial intelligence (AI) electrocardiogram (ECG) market is driven by concerns regarding the growing prevalence of cardiovascular diseases. For instance, according to the WHO report, cardiovascular diseases are the leading cause of death worldwide, with an estimated 19.8 million deaths from CVDs in the year 2022, which represents 32% of all global deaths. The increasing adoption of remote patient monitoring and telehealth services, including wearable ECG devices with the use of generative AI, for gathering continuous, accurate health data, aids in propelling the market growth. In addition, the expanding awareness regarding cardiac health and its early diagnosis through public education campaigns, free health screenings, and community events is contributing to promoting the market.

Restraining Factors

The artificial intelligence (AI) electrocardiogram (ECG) market is restricted by surging concerns regarding data security and protection. Further, the lack of standardization in AI algorithms and ECG data interpretation, which hinders its adoption, especially in the underdeveloped regions, is challenging the market growth. 

Market Segmentation

The artificial intelligence (AI) electrocardiogram (ECG) market share is classified into type and application.   

• The cloud based segment dominated the market with the largest revenue share of over 71% in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the type, the artificial intelligence (AI) electrocardiogram (ECG) market is divided into on-premised and cloud-based. Among these, the cloud based segment dominated the market with the largest revenue share of over 71% in 2024 and is projected to grow at a substantial CAGR during the forecast period. The cloud-based solutions offer a faster, scalable, and patient-friendly approach to ECG analysis, reducing the time required for data analysis by 40% and cutting costs by 35%, thus reducing the time required for manual data processing. The adaptability and versatility of cloud-based AI ECG for handling information on far-off servers, enabling working with remote observing and telemedicine applications, is driving the segmental market growth. 

• The hospital segment accounted for the largest share of over 40% in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the application, the artificial intelligence (AI) electrocardiogram (ECG) market is divided into hospital and clinic. Among these, the hospital segment accounted for the largest share of over 40% in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The development of an artificial intelligence tool helps doctors identify people at risk of developing a potentially fatal heart condition, from the use of ECG. For instance, the EchoNext AI model efficacy reveals that the tool outperforms skilled cardiologists in detecting hidden structural heart disease, signalling a paradigm shift in cardiac screening. The use of AI ECG frameworks in hospital settings for upgrading symptomatic precision and productivity of cardiovascular care is driving the market demand.

Regional Segment Analysis of the Artificial Intelligence (AI) Electrocardiogram (ECG) Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the artificial intelligence (AI) electrocardiogram (ECG) market over the predicted timeframe.

North America is anticipated to hold the largest share of over 40% in the artificial intelligence (AI) electrocardiogram (ECG) market over the predicted timeframe. The market ecosystem in North America is strong, with well-represented leading AI healthcare startup companies like Tempus and Noah Labs that are developing medical devices with AI-integrated system. The demand for artificial intelligence (AI) electrocardiogram (ECG) has been driven by the region's increasing need for early and accurate diagnosis of cardiac conditions, along with the increasing prevalence of cardiovascular conditions and the geriatric population. For instance, in January 2025, Sutter Health and GE HealthCare announced a seven-year strategic enterprise partnership to benefit patients, physicians and clinicians with advanced, AI-powered imaging. The U.S. is dominating the North America artificial intelligence (AI) electrocardiogram (ECG) market, due to the launch of innovative solutions, along with the growing prevalence of cardiovascular diseases and the geriatric population.

Asia Pacific is expected to grow at a rapid CAGR of about 15% in the artificial intelligence (AI) electrocardiogram (ECG) market during the forecast period. The Asia Pacific area has a thriving market for artificial intelligence (AI) electrocardiogram (ECG) due to an increasing government support for healthcare AI and favourable regulatory policies for approving AI cardiac devices. Further, an increasing research and implementation of AI-powered ECG, with an increasing research and local initiatives, are supporting the market. For instance, in June 2025, South Korea’s Ministry of Food and Drug Safety approved Vuno Inc.’s AI-based Med-DeepECG Kidney software as a non-invasive method to screen for kidney dysfunction. China is the dominating country in the Asia Pacific artificial intelligence (AI) electrocardiogram (ECG) market during the forecast period, driven by the growing emphasis on preventative healthcare, along with an upsurge in innovations in ECG technology.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the artificial intelligence (AI) electrocardiogram (ECG) market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• iRhythm Technologies Inc.
• Viz.ai Inc.
• Tempus Labs Inc.
• HeartSciences Inc.
• Neurosoft Software Production S.A.
• Tricog Health Services Pvt. Ltd.
• Anumana Inc.
• IDOVEN S.L.
• Ultromics Limited.
• VUNO Inc.
• Cardio.AI Inc.
• Powerful Medical s.r.o.
• RSIP Vision Ltd.
• AccurKardia Inc.
• Cardiologs Technologies SAS
• Cardiomatics Sp. z o.o.
• Cordys Analytics B.V.
• PulseAI Ltd.
• Vektor Medical Inc.
• DeepECG Inc
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In October 2025, MD Onboard is expanding its role in aviation health innovation through two technology partnerships with CardioSecur, a German-based developer of advanced mobile ECG technology, and HPE Innovation, a U.S. company specializing in artificial intelligence-driven biometric monitoring.

• In July 2025, Royal Philips, a global leader in health technology, announced the launch of the Philips ECG AI Marketplace, a platform that gives cardiac care teams access to multiple vendor offerings all in one central location to help clinicians manage and implement AI-powered diagnostic tools more easily.

• In July 2022, Anumana, Inc., an AI-driven health technology company and portfolio company of nference, launched a multi-year strategic collaboration with Novartis Pharmaceuticals Corporation to deploy a series of artificial intelligence (AI)-powered software solutions that would detect hidden cardiovascular conditions.  

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the artificial intelligence (AI) electrocardiogram (ECG) market based on the below-mentioned segments:  

Global Artificial Intelligence (AI) Electrocardiogram (ECG) Market, By Type   

• On-Premised
• Cloud-Based

Global Artificial Intelligence (AI) Electrocardiogram (ECG) Market, By Application   

• Hospital
• Clinic

Global Artificial Intelligence (AI) Electrocardiogram (ECG) Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa